Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000047

CFO and Secretary sold 10,757 shares at $13.57 ($146,004)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Levy Adam Scott CFO and Secretary 2024-10-11 Sale 10b5-1 −10,757 $13.57 $146,004 236,854 D
Open-market sales · 10,757 sh · avg $13.57 · $146,004
Loading xslF345X05/wk-form4_1729023737.xml…